For patients with localized prostate cancer (PCa), tissue-based genomic classifiers (GCs) do not consistently influence risk ...

TrialTranslator uses machine learning to assess cancer RCT generalizability, revealing survival gaps for high-risk patients ...

Background The immune suppression mechanisms in pancreatic ductal adenocarcinoma (PDAC) remain unknown, but preclinical ...

Prostate-Specific Membrane Antigen (PSMA) is a highly expressed and structurally unique target specific to prostate cancer (PCa). Diagnostic and therapeutic approaches in nuclear medicine, coupling ...

We work right across the cancer research pathway with strengths ranging from cell biology to healthcare research. We aim to nurture the thought leaders of today and tomorrow through the provision of ...

Colon cancer symptoms in women include diarrhea, constipation, unintended weight loss, and bloody stools. While these are the same for anyone with colon cancer, symptoms in women may be misattributed ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Aggressive prostate cancer (PCa) variants ...

The signs and symptoms of prostate cancer may include frequent urination, urgency, or a need to urinate during the night. Men may also notice that they have difficulty starting to urinate, as well as ...

Can prostate supplements help reduce the risk of prostate cancer? While there is no definitive evidence that prostate supplements can reduce the risk of prostate cancer, some natural ingredients ...

Jan. 3, 2025 — A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously ... Dec. 19, 2024 — There are several ...